Testing version — LOERadar is in active testing. Features and data may change.
RIFAPENTINE (RIFAPENTINE) | LOERadar
Tentative Approval — This application has been tentatively approved by the FDA but is not yet listed in the Orange Book. It is blocked from final approval by unexpired patents or exclusivities on the reference listed drug.
RIFAPENTINE
ANDATentative Approval
RIFAPENTINE | A217042 | MACLEODS PHARMS LTD
Products (1)
#001 — 150MG
▴
TABLET;ORAL | Approved: 2026-06-23 00:00:00
No patent or exclusivity listings for this strength.